North Run Strategic Opportunities Fund has liquidated its entire $50m (approximately £39.5m) position in LightPath Technologies, a Florida-based manufacturer of infrared optics and photonic components. The transaction, disclosed in a regulatory filing, represents a complete exit from the holding, which had been a significant part of the fund's alternative technology allocation.
LightPath Technologies, listed on the Nasdaq under the ticker LPTH, saw its share price drop 4.2% on the day of the filing, closing at $2.85. The company specialises in precision optical components used in defence, medical imaging, and industrial sensing. North Run's decision to divest entirely suggests a reassessment of the risk-reward profile in the small-cap optics sector.
Analysts at London-based Edison Group noted that North Run's exit may reflect broader caution among institutional investors toward US-listed micro-cap stocks, which have underperformed the wider market this year. 'Funds are rotating out of speculative tech plays into more liquid, larger-cap names,' said a senior analyst at the firm. 'This is consistent with a trend we've seen since the start of the third quarter.'
For UK investors, the sale has indirect implications. North Run Strategic Opportunities Fund is registered in the Channel Islands and has a notable British institutional investor base, including several UK pension schemes. The fund's move could signal a shift away from high-growth, high-volatility US equities, which may affect UK portfolio allocations to similar strategies.
LightPath Technologies has not commented on the sale, but its recent quarterly results showed a 6% decline in revenue year-on-year, partly due to supply chain delays. The company continues to hold a strong order book in defence contracts, but the fund's exit raises questions about near-term growth prospects. Source: SEC filing 13D/A.